Verdiva Bio
Drug Discovery
Verdiva Bio valuation and funding history | Last updated: January 9, 2025 | 1 funding rounds
Current Valuation
N/A
As of January 9, 2025
Total Funding Raised
N/A
Across 1 round
Last Round
Early Stage VC (Series A)
$411.0M
Last Funding
Jan 2025
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| January 9, 2025 | Early Stage VC (Series A) | $411.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Verdiva Bio is currently valued at N/A as of January 9, 2025.
What is Verdiva Bio Worth in 2026?
Verdiva Bio is a leading private company in the Drug Discovery sector. Track Verdiva Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Verdiva Bio Valuation is Determined
Private company valuations like Verdiva Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.